Indian Journal of Psychological Medicine
  Home | About Us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Contact | Advertise | Submission | Login 
Users Online: 798 
Wide layoutNarrow layoutFull screen layoutHome Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Can interleukin-2 and interleukin-1ß be specific biomarkers of negative symptoms in schizophrenia?
Leticia González-Blanco,María P. García-Portilla,Leticia García-Álvarez,Lorena de la Fuente-Tomás,Celso Iglesias García,Pilar A. Sáiz,Susana Rodríguez-González,Ana Coto-Montes,Julio Bobes
Revista de Psiquiatría y Salud Mental (English Edition).2019;12(1)9
[DOI]
2Reduced Annexin A3 in schizophrenia
Helena P. G. Joaquim,Alana Caroline Costa,Maurício Henriques Serpa,Leda L. Talib,Wagner F. Gattaz
European Archives of Psychiatry and Clinical Neuroscience.2019;12(1)9
[DOI]
3¿Pueden ser la interleucina-2 y la interleucina-1ß biomarcadores específicos de la sintomatología negativa en la esquizofrenia?
Leticia González-Blanco,María P. García-Portilla,Leticia García-Álvarez,Lorena de la Fuente-Tomás,Celso Iglesias García,Pilar A. Sáiz,Susana Rodríguez-González,Ana Coto-Montes,Julio Bobes
Revista de Psiquiatría y Salud Mental.2019;12(1)9
[DOI]
 Home
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal